On Thursday, Sun Pharmaceutical Industries announced that it has requested shareholders' consent for related-party transactions (RPTs) totaling about $1 billion for FY26...
Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of Novem...
AstraZeneca Pharma India is set to sell its 64-acre production facility in North Bengaluru as part of a strategic review of its global manufacturing and supply network by its parent company. The deal is expected to generate over ?3,200 crore and a...
Uniphar, a global partner for pharmaceutical and medtech manufacturers, is enhancing its international reach by opening three new facilities, strategically located in major global markets such as Raleigh, Lelystad, and Dublin. Uniphar's recent...
AGC Pharma Chemicals, a leader in pharmaceutical manufacturing with more than 40 years of experience in Contract Development Manufacturing Operations (CDMO) for small molecule APIs located in Barcelona (Spain) and Japan, is enhancing its High...
Dr. Ashwani Kumar, Ex-Chief Manufacturing & Compliance Officer, Unichem Laboratories Limited, in an exclusive interview with India Pharma Outlook, shares his views on how the pharmaceutical industry manages cost efficiency while maintaining...
Ardena, a focused pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) operating in Belgium, Spain, the Netherlands, and Sweden, has finalized its acquisition of Catalent...
Industry experts from the healthcare segment made their remarks post-budget 2025. The budget strengthens India's commitment to health innovation, inclusive growth and improved access to nutrition. The exemption of around 40 life-saving drugs from...
Jupiter Neurosciences Inc., a pharmaceutical company in the clinical stage, is developing JOTROL, a patented platform based on resveratrol, and has reached an agreement with Catalent Pharma Solutions LLC to produce JOTROL softgel capsules to...
Vanda Pharmaceuticals Inc. and AnaptysBio, Inc. announced an exclusive worldwide licensing agreement for the development and marketing of imsidolimab (IL-36R antagonist mAb), which has successfully finished two registration-supporting global Phase...
, CDSCO.jpg)
